OMDA · NASDAQ · STOCK
Omada Health
$24.00
52W $10.28 – $26.91
59/100
$1.43B
353.6
1.72
Is OMDA Bullish or Bearish?
Bullish.
Innellis AI committee rates Omada Health (OMDA) Buy with a composite score of 59/100
, based on 4 analysts with 50% agreement.
Last updated August 11, 2026.
What Would Change This View
- Upgrade to Strong Buy
- Requires a committee score of 75.0 — +16.45 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Watch
- Requires the score to fall below 55.0 — -3.55 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Risk Analyst remains cautious — bollinger bandwidth of 35.5% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
- Trend and market structure agree -- coherent bullish picture — Technical
- VIX regime is low -- calm backdrop supports risk-taking — Macro
- Market regime is bullish (Bull market -- normal position sizing) — Macro
- News sentiment is positive (+0.17 across 6 articles, 14d) — News
Bear Case
- Daily trend (uptrend) conflicts with the weekly trend (downtrend) -- fighting the larger trend — Technical
- Bollinger bandwidth of 35.5% signals elevated volatility — Risk
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of August 11, 2026
Overall Committee Score
59/100
Agreement
50%
Analysts
4
Conviction
Contested
Sector Rank
Top 59%
of 192 Healthcare peers
Technical Analyst
neutral
59
/ 100 · High confidence
Mixed or range-bound price action
+ Price structure making higher highs and higher lows
− Daily trend (uptrend) conflicts with the weekly trend (downtrend) -- fighting the larger trend
Risk Analyst
bearish
35
/ 100 · Low confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− Bollinger bandwidth of 35.5% signals elevated volatility
Macro Analyst
bullish
78
/ 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ VIX regime is low -- calm backdrop supports risk-taking
News Analyst
bullish
63
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.17 across 6 articles, 14d)
Portfolio Manager
neutral
55
/ 100 · Moderate confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− 2 existing position pair(s) are highly correlated already
Technical Analysis
RSI (14)
66.6
Neutral
MACD Histogram
0.295
Bullish Momentum
Trend Direction
Uptrend
Weekly: Downtrend
Market Structure
Hh Hl
Support
$14.20
Resistance
$24.50
Bollinger %B
0.80
Inside Bands
Price vs Moving Averages
EMA 9
$22.13
Above
EMA 21
$21.59
Above
EMA 50
$20.40
Above
EMA 200
$18.24
Above
Fundamental Analysis
Valuation
45
Profitability
27
Financial Health
100
Cash Flow
70
Valuation
P/E Ratio
353.6×
P/B Ratio
5.67×
PEG Ratio
0.57
Dividend Yield
0.00%
52W High
$26.91
52W Low
$10.28
Quality & Growth
ROE
-556.3%
ROA
-418.4%
Gross Margin
6818.6%
Operating Margin
-15.0%
Revenue Growth YoY
—
Debt / Equity
0.00
AI Fundamental Assessment
[reduced confidence: limited earnings history] P/E ratio of 353.6 (rich relative to a 15-40x range); Price-to-book of 5.7x; PEG ratio of 0.6 (under 1.0 suggests growth is undervalued relative to price); Return on equity of -5.6%; Return on assets of -4.2%; Net margin of 1.4%; Gross margin of 68.2%; Current ratio of 3.91 (healthy short-term liquidity); Debt-to-equity of 0.00; Free cash flow per share is positive (0.38); Earnings-history trend unavailable; growth based on TTM year-over-year only.
Get the Full OMDA Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →